参 考 文 献
[ 1 ] Durkan A, Hodson EM. Non2corticosteroid treatment for nephroticsyndrome in children. Cochrane Database of SystematicReviews,2001, 4: 2290.
[ 2 ] Shimomura Y,MurakamiM. Imp rovement of nephrotic syndrome in amassively obese patient afterweight loss and treatmentwith an anti2allergic drug. J Med Drug, 1990, 21: 3372347.
[ 3 ] Geier P, Jurencak R, Zap letalova J. Treatment of the first ep isode ofnephrotic syndrome in children. Pediatr Nephrol, 2006, 21:177921780.
[ 4 ] Abeya AS. Treatment of steroid sensitive nephrotic syndrome. IndianJ Pediatr, 2005, 72: 7632769.
[ 5 ] Saito T. Advance in the treatment of p rogressive renal dysfunctionnephrotic syndrome. Nihon Naika Gakkai zasshi. , 2004, 93:90629011.
[ 6 ] Dong F, Zhou X, Pang N. et al. Effect of glucocorticoid treatment oninsulin like growth factor2I and its binding p roteins in children withnephrotic syndrome. Chin Med J Chinese Medical Journal, 2002,115: 138321385.
[ 7 ] Schwarz A. New aspects of the treatment of nephrotic syndrome.JASN, 2001, 12 (17) : 44247.
[ 8 ] Castellano. Remission of nephrotic syndrome caused by renal amy2loidosis secondary to pulmonary tuberculosis after tuberculostatictreatment. Nefrologia, 2001, 21: 88291.
[ 9 ] Goszczyk A. The effect of treatmentmethods on frequency of relap sein nephrotic syndrome in children. Polski Merkuriusz Lekarski,2000, 9 (1) : 25226.
[ 10 ] Gheith OA, SobhMA,Mohamed Kel2S. et al. Impact of treatment ofdyslip idemia on renal function, fat deposits and scarring in patientswith persistent nephrotic syndrome. Nephron, 2002, 91: 6122619.
[ 11 ] Frassinetti, Fernandes P,Bezerra Da, et al. Treatment of steroid2re2sistant nephrotic syndrome with cyclosporine: study of 17 cases anda literature review. J Nephrol, 2005, 18 (6) : 7112720.
[ 12 ] Kausman JY, Yin L, Jones CL, et al. Vincristine treatment in ster2oid2dependent nephrotic syndrome. Pediatr Nephrol, 2005, 20:141621419.
[ 13 ] Soma J, Sato H. Nephrotic syndrome associated with hypocomp le2mentaemic urticarial vasculitis syndrome: successful treatment withcyclosporin A. Nephrol Dial Transp lant, 1999, 14: 175321757.
[ 14 ] Querfeld U, Kohl B, Fiehn W, et al. Probucol for treatment of hy2perlip idemia in persistent childhood nephrotic syndrome. PediatrNephrol, 1999, 13: 7212.
[ 15 ] Prasher PK, Varma PP, Baliga KV. Efficacy of enalap ril in thetreatment of steroid resistant idiopathic nephrotic syndrome. J AssocPhysicians India, 1999, 47: 1802182.
[ 16 ] Islek I, Gok F,Albayrak D, et al. Nephrotic syndrome following ce2fixime therapy in a 102month2old girl: spontaneous resolution.Nephrol Dial Transp lant, 1999, 14: 25227.
[ 17 ] Reshaid K. Treatment of children with steroid refractory idiopathicnephrotic syndrome: the Kuwaiti experience. Renal failure, 1999,21: 4872494.
[ 18 ] Chan TM, Li FK, Hao WK, et al. Treatment of membranous lupusnephritis with nephrotic syndrome by sequential immunosupp res2sion. Lupus, 1999, 8: 5452551.
[ 19 ] Charlesworth JA, Gracey DM, Pussell BA. Adult nephrotic syn2drome: non2specific strategies for treatment. Nephrology, 2008, 13:45250.
[ 20 ] Sonmez A. Hyperbaric oxygen treatment augments the efficacy ofcilazap ril and simvastatin regimens in an experimental nephroticsyndrome model. Clin Exp Nephrol, 2008, 12: 1102118.
[ 21 ] Ehrich JH, Pape L, Schiffer M. Corticosteroid2resistant nephroticsyndrome with focal and segmental glomerulosclerosis: an update oftreatment op tions for children. PaediatrDrugs, 2008, 10: 9222.
[ 22 ] Nie L. Clinical experience in TCM treatment of refractory nephroticsyndrome. J Tradit ChinMed, 2008, 28: 46248.